&Partners’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
27,031
+864
+3% +$36.6K ﹤0.01% 1323
2026
Q1
$1.02M Buy
26,167
+2,947
+13% +$120K 0.01% 1287
2025
Q4
$948K Buy
23,220
+1,431
+7% +$58.2K 0.01% 1248
2025
Q3
$879K Buy
21,789
+1,209
+6% +$46.6K 0.01% 1152
2025
Q2
$757K Buy
20,580
+2,453
+14% +$83.1K 0.01% 1130
2025
Q1
$598K Buy
18,127
+8,280
+84% +$288K 0.01% 1051
2024
Q4
$345K Buy
+9,847
New +$346K ﹤0.01% 1259

Other funds holding RECS

&Partners's RECS Position: Q2 2026 in Review

&Partners increased its Columbia Research Enhanced Core ETF (RECS) stake by 3.3% in Q2 2026, buying an estimated $36.6K and bringing the position to 27,031 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1323.

&Partners first reported a position in RECS in Q4 2024 and has held it in 7 quarters since. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • &Partners held 27,031 shares of Columbia Research Enhanced Core ETF worth $1.17M as of Q2 2026.
  • &Partners bought 864 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $36.6K.
  • Columbia Research Enhanced Core ETF made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1323 holding.
  • &Partners first reported a position in Columbia Research Enhanced Core ETF in Q4 2024 and has held it in 7 quarters since.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.